These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 34250391)
1. Comprehensive Clinical and Molecular Characterization of Henry JT; Coker O; Chowdhury S; Shen JP; Morris VK; Dasari A; Raghav K; Nusrat M; Kee B; Parseghian C; Pant S; Jeyakumar N; Zhu L; Nishioka Y; Fogelman D; Wolff RA; Hong D; Overman MJ; Vauthey J; Kopetz S; Johnson B JCO Precis Oncol; 2021; 5():. PubMed ID: 34250391 [TBL] [Abstract][Full Text] [Related]
2. The Prognostic Impact of KRAS G12C Mutation in Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Observational Study. Chida K; Kotani D; Masuishi T; Kawakami T; Kawamoto Y; Kato K; Fushiki K; Sawada K; Kumanishi R; Shirasu H; Matsubara Y; Yuki S; Komatsu Y; Yamazaki K; Yoshino T Oncologist; 2021 Oct; 26(10):845-853. PubMed ID: 34232546 [TBL] [Abstract][Full Text] [Related]
3. Real-World Study of Characteristics and Treatment Outcomes Among Patients with KRAS p.G12C-Mutated or Other KRAS Mutated Metastatic Colorectal Cancer. Fakih M; Tu H; Hsu H; Aggarwal S; Chan E; Rehn M; Chia V; Kopetz S Oncologist; 2022 Aug; 27(8):663-674. PubMed ID: 35472176 [TBL] [Abstract][Full Text] [Related]
4. KRAS G12C Metastatic Colorectal Cancer: Specific Features of a New Emerging Target Population. Schirripa M; Nappo F; Cremolini C; Salvatore L; Rossini D; Bensi M; Businello G; Pietrantonio F; Randon G; Fucà G; Boccaccino A; Bergamo F; Lonardi S; Dei Tos AP; Fassan M; Loupakis F Clin Colorectal Cancer; 2020 Sep; 19(3):219-225. PubMed ID: 32605718 [TBL] [Abstract][Full Text] [Related]
5. A Multicenter Retrospective Chart Review of Clinical Outcomes Among Patients With KRAS G12C Mutant Non-Small Cell Lung Cancer. Iams WT; Balbach ML; Phillips S; Sacher A; Bestvina C; Velcheti V; Wang X; Marmarelis ME; Sethakorn N; Leal T; Sackstein PE; Kim C; Robinson MA; Mehta K; Hsu R; Nieva J; Patil T; Camidge DR Clin Lung Cancer; 2023 May; 24(3):228-234. PubMed ID: 36841727 [TBL] [Abstract][Full Text] [Related]
8. Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group. Modest DP; Ricard I; Heinemann V; Hegewisch-Becker S; Schmiegel W; Porschen R; Stintzing S; Graeven U; Arnold D; von Weikersthal LF; Giessen-Jung C; Stahler A; Schmoll HJ; Jung A; Kirchner T; Tannapfel A; Reinacher-Schick A Ann Oncol; 2016 Sep; 27(9):1746-53. PubMed ID: 27358379 [TBL] [Abstract][Full Text] [Related]
9. [Gene mutation profiles and clinicopathological features of patients with non-small cell lung cancer harboring KRAS G12C mutation: a single-center retrospective study]. Guo LY; Xiang C; Zhao RY; Chen SN; Ma SJ; Han YC Zhonghua Bing Li Xue Za Zhi; 2023 Feb; 52(2):117-123. PubMed ID: 36748130 [No Abstract] [Full Text] [Related]
10. Retrospective Comparative Analysis of KRAS G12C Giampieri R; Lupi A; Ziranu P; Bittoni A; Pretta A; Pecci F; Persano M; Giglio E; Copparoni C; Crocetti S; Mandolesi A; Faa G; Coni P; Scartozzi M; Berardi R Front Oncol; 2021; 11():736104. PubMed ID: 34660299 [TBL] [Abstract][Full Text] [Related]
11. Impact of genetic profiles on the efficacy of anti-EGFR antibodies in metastatic colorectal cancer with KRAS mutation. Kishiki T; Ohnishi H; Masaki T; Ohtsuka K; Ohkura Y; Furuse J; Sugiyama M; Watanabe T Oncol Rep; 2014 Jul; 32(1):57-64. PubMed ID: 24839940 [TBL] [Abstract][Full Text] [Related]
12. Not All Kirsten Rat Sarcoma Viral Oncogene Homolog Mutations Predict Poor Survival in Patients With Unresectable Colorectal Liver Metastasis. Lin Z; Liu Y; Cai S; Yang C; Zhou L; Li W Technol Cancer Res Treat; 2021; 20():15330338211039131. PubMed ID: 34669528 [No Abstract] [Full Text] [Related]
13. Targeting Ros J; Vaghi C; Baraibar I; Saoudi González N; Rodríguez-Castells M; García A; Alcaraz A; Salva F; Tabernero J; Elez E Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542278 [TBL] [Abstract][Full Text] [Related]
14. Activity and resistance to KRAS Ye W; Lu X; Qiao Y; Ou WB Biochim Biophys Acta Rev Cancer; 2024 May; 1879(3):189108. PubMed ID: 38723697 [TBL] [Abstract][Full Text] [Related]
15. Characterizing the Li M; Keshavarz-Rahaghi F; Ladua G; Swanson L; Speers C; Renouf DJ; Lim HJ; Davies JM; Gill S; Stuart HC; Yip S; Loree JM Ther Adv Med Oncol; 2022; 14():17588359221097940. PubMed ID: 35694189 [TBL] [Abstract][Full Text] [Related]